Life-threatening renal failure caused by vasomotor nephropathy associated with nonsteroidal anti-inflammatory drugs

International Journal of Clinical Pharmacology Research

Volumn 24, Issue 4, 2004, Pages 117-122

  Horackova, Miroslava ^a,b   Charvat, J ^a   Hasa, J ^a   Forejt, J ^a   Kvapil, M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CONTRAST MEDIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ANALGESIC NEPHROPATHY; ARTICLE; COHORT ANALYSIS; DEHYDRATION; FEMALE; HEMODIALYSIS; HIGH RISK POPULATION; HUMAN; HYPOTENSION; HYPOVOLEMIA; INTENSIVE CARE; KIDNEY BLOOD FLOW; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PREVALENCE; PROSPECTIVE STUDY; PUBLICATION; RISK FACTOR; UREMIA; URINARY TRACT OBSTRUCTION; VASCULAR NEPHROPATHY; VASOMOTOR DISORDER; VASOMOTOR NEPHROPATHY;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; RISK FACTORS; UREMIA; VASOMOTOR SYSTEM;

EID: 14244267397     PISSN: 02511649     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Felson D.T., Zhan Y. An update of epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum., 41(8), 1134, 1998.
2. Miehle W. "Chronische Polyarthritis. Diagnosis und Therapie." Eular Verlag., Basel, 1994, pp. 2-28.
3. Klener P. Lécba bolesti nádorových onemocnení. Remedia, 5, 30, 1995.
4. Štika L., Dvořák P., Horácková M., et al. Cesko-Slovenské konference klinické farmakologie, Rožnov pod Radhoštem, 2003, Abstr. No. 38.
5. Schnitzer T.J. Non-NSAID pharmacologic treatment options for the management of chronic pain. Am. J. Med., 105(1B), 45, 1998.
6. Andreucci V.E., Fuiano G., Russo D., Andreucci M. Vasomotor nephropathy in the elderly. Nephrol. Dial. Transplant., 13(S7), 7, 1998.
7. Delmas P.D. Nonsteroidal anti-inflammatory drugs and renal function. Br. J. Rheumatol., 34(S1), 25, 1995.
8. Schwarz J.I., Vandomael K., Malice M.P., et al. Comparison of rofecoxib, celecoxib and naproxen on renal function in elderly subjects receiving a normal-salt diet. Clin. Pharmacol. Ther., 72(1), 50, 2002.
9. Swendsen K.B., Bech J.N., Sorensen T.B., Pedersen E.B. A comparison of the effects of etodolac and ibuprofen on renal haemodynamics, tubular function, renin, vasopressin and urinary excretion of albumin and alpha-glutathion-S- transferase in healthy subjects: A placebo-controlled cross-over study. Eur. J. Clin. Pharmacol., 56(5), 383, 2000.
10. Dilger K., Herrlinger C., Peters J., Seyberth H.W., Schweer H., Klotz U. Effects of celecoxib and diclofenac on blood pressure, renal function, and vasoactive prostanoids in young and elderly subjects. J.Clin. Pharmacol., 42(9), 985, 2002.
11. DeMaria A.N., Weir M.R. Coxibs - Beyond the GI tract: Renal and cardiovascular issues. J. Pain. Symp. Manag., 25(2), 41, 2003.
12. Griffin M.R., Yared A., Ray W.A. Nonsteroidal anti-inflammatory drugs and acute renal failure in elderly persons. Am. J. Epidemiol., 151(1), 488, 2000.
13. Whelton A., Schulman G., Wallemark C., et al. Effects of celecoxib and naproxen on renal function in elderly. Arch. Intern. Med, 160(10), 1465, 2000.
14. Niccoli L., Bellino S., Cantini F. Renal tolerability of three employed non-steroidal anti-inflammatory drugs in elderly patients with osteoarthritis. Clin. Exp. Rheumatol., 20(2), 201, 2002.
15. Woywodt A., Schwarz A., Mengel M., Haller H., Zeidler H., Kohler L. Nephrotoxicity of selective COX-2 inhibitors. J. Rheumatol., 28(9), 2133, 2001.
16. Badid C., Chambrier C., Aouifi A., Boucaud C., Bouletreau P. Non-steroidal anti-inflammatory agents and angiotensin converting enzyme inhibitors: A dangerous combination during the postoperative period. Ann. Fr. Anesth. Reanim., 16(1), 55, 1997.
17. Bennett W.M. Drug interaction and consequences of sodium restriction. Am. J. Clin. Nutr., 65(S2), S678, 1997.
18. Stocic Z., Sedlak V., Curic S., Fellé D., Budakov P., Tepavcevic P. Effects of nonsteroidal anti-inflammatory drugs on renal plasma flow and glomerular filtration rate in patients with glomerulonephritis. Med. Pregl., 46(S1), 36, 1993.
19. Swan S.K., Rudy D.W., Lasseter K.C., et al. Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. Ann. Intern. Med., 133(1), 1, 2000.
20. Abuelo J.G. Diagnosis vascular causes of renal failure. Ann. Intern. Med., 123(SI 8), S601, 1999.
21. Baraldi A., Ballestri M., Rapaná L. Acute renal failure of medical type in elderly population. Nephrol. Dial. Transplant., 13(S7), 25, 1998.
22. Horácková M., Šafářova R., Vanková S., Forejt J., Háša J., Bahbouh R. "Medikamentös induzierte Nierenschädigung bei älteren Patienten. Werkstattgespräch Nephrologie III." PABST, Berlin, 2001, pp. 30-39.